Abiopharma

Sensenig Bethany 🟢 acquired 12.5K shares (1 derivative) of Alpha Cognition Inc. (ACOG) at $6.65 Transaction Date: Apr 16, 2026 | Filing ID: 000624

New Form 4/A - ROCKWELL MEDICAL, INC. <b>Filed:</b> 2026-04-17 <b>AccNo:</b> 0001104659-26-045050 <b>Size:</b> 6 KB

New Form 4/A - ROCKWELL MEDICAL, INC. <b>Filed:</b> 2026-04-17 <b>AccNo:</b> 0001104659-26-045049 <b>Size:</b> 6 KB

New Form 4/A - ROCKWELL MEDICAL, INC. <b>Filed:</b> 2026-04-17 <b>AccNo:</b> 0001104659-26-045046 <b>Size:</b> 6 KB

📋 Coen Steven P. (Officer) plans to sell 324 shares of Ginkgo Bioworks Holdings, Inc. (at $7.95 each, total $3K) Filed: Apr 17, 2026 | ID: 002973

New Form 3 - GOLDMAN SACHS GROUP INC <b>Filed:</b> 2026-04-17 <b>AccNo:</b> 0000886982-26-000098 <b>Size:</b> 7 KB

New Form 3 - TGE Value Creative Solutions Corp <b>Filed:</b> 2026-04-17 <b>AccNo:</b> 0000886982-26-000098 <b>Size:</b> 7 KB

New Form SCHEDULE 13G - Versamet Royalties Corp <b>Filed:</b> 2026-04-17 <b>AccNo:</b> 0001104659-26-045027 <b>Size:</b> 7 KB

New Form 3 - GH Research PLC <b>Filed:</b> 2026-04-17 <b>AccNo:</b> 0001140361-26-015418 <b>Size:</b> 17 KB

(19% Negative) ZENTALIS PHARMACEUTICALS, INC. (ZNTL) Announces Delay in approach Trials for Cancer Research (AACR) Annual Meeting Due to Regulatory Process, Safety Review, Efficacy Assessment